D. E. Shaw & Co., Inc. - ARBUTUS BIOPHARMA CORP ownership

ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 110 filers reported holding ARBUTUS BIOPHARMA CORP in Q2 2022. The put-call ratio across all filers is 0.82 and the average weighting 0.2%.

Quarter-by-quarter ownership
D. E. Shaw & Co., Inc. ownership history of ARBUTUS BIOPHARMA CORP
ValueSharesWeighting
Q1 2022$59,000
-33.7%
19,698
-14.0%
0.00%
Q4 2021$89,000
+122.5%
22,900
+18.7%
0.00%
Q2 2019$40,000
-76.7%
19,300
-59.8%
0.00%
Q1 2019$172,000
-6.5%
48,0470.0%0.00%
Q4 2018$184,000
-67.8%
48,047
-20.7%
0.00%
-100.0%
Q3 2018$572,000
-83.3%
60,556
-87.1%
0.00%
-75.0%
Q2 2018$3,435,000
-3.3%
470,508
-33.8%
0.00%
-20.0%
Q1 2018$3,552,000
-41.7%
710,462
-41.1%
0.01%
-37.5%
Q4 2017$6,091,000
-44.0%
1,206,125
-31.2%
0.01%
-52.9%
Q3 2017$10,875,000
+74.2%
1,754,105
+1.1%
0.02%
+70.0%
Q2 2017$6,244,000
+9.9%
1,734,529
-0.7%
0.01%0.0%
Q1 2017$5,679,000
+33.6%
1,747,102
+0.7%
0.01%
+42.9%
Q4 2016$4,250,000
-28.2%
1,734,603
+0.8%
0.01%
-30.0%
Q3 2016$5,920,000
-2.3%
1,720,981
-1.2%
0.01%
-9.1%
Q2 2016$6,062,000
-14.2%
1,741,895
+1.8%
0.01%
-15.4%
Q1 2016$7,069,000
-15.1%
1,711,569
-8.5%
0.01%
+8.3%
Q4 2015$8,328,000
-26.4%
1,871,460
+0.8%
0.01%
-29.4%
Q3 2015$11,310,0001,857,0760.02%
Other shareholders
ARBUTUS BIOPHARMA CORP shareholders Q2 2022
NameSharesValueWeighting ↓
JACOB ASSET MANAGEMENT OF NEW YORK LLC 340,000$1,459,0000.53%
RTW INVESTMENTS, LP 4,733,323$20,306,0000.31%
APIS CAPITAL ADVISORS, LLC 70,000$300,0000.29%
Hudson Bay Capital Management LP 1,800,000$7,722,0000.10%
COWEN AND COMPANY, LLC 249,215$1,069,0000.05%
Kerrisdale Advisers, LLC 100,000$429,0000.05%
Woodline Partners LP 496,172$2,129,0000.04%
Shay Capital LLC 60,000$257,0000.03%
Walleye Capital LLC 231,037$991,0000.03%
BOOTHBAY FUND MANAGEMENT, LLC 212,700$912,0000.02%
View complete list of ARBUTUS BIOPHARMA CORP shareholders